Fintel reports that on June 4, 2023, RESEARCH CAPITAL CORPORATION maintained coverage of Theratechnologies (TSX:TH) with a Buy recommendation.
What is the Fund Sentiment?
There are 40 funds or institutions reporting positions in Theratechnologies. This is an increase of 4 owner(s) or 11.11% in the last quarter. Average portfolio weight of all funds dedicated to TH is 0.04%, a decrease of 34.35%. Total shares owned by institutions decreased in the last three months by 0.25% to 24,728K shares.
What are Other Shareholders Doing?
Soleus Capital Management holds 9,091K shares representing 9.37% ownership of the company. In it's prior filing, the firm reported owning 8,799K shares, representing an increase of 3.21%. The firm decreased its portfolio allocation in TH by 31.58% over the last quarter.
AIGH Capital Management holds 3,408K shares representing 3.51% ownership of the company. In it's prior filing, the firm reported owning 3,830K shares, representing a decrease of 12.37%. The firm decreased its portfolio allocation in TH by 27.72% over the last quarter.
Worth Venture Partners holds 847K shares representing 0.87% ownership of the company. In it's prior filing, the firm reported owning 952K shares, representing a decrease of 12.45%. The firm decreased its portfolio allocation in TH by 30.71% over the last quarter.
National Bank Of Canada holds 519K shares representing 0.53% ownership of the company. In it's prior filing, the firm reported owning 521K shares, representing a decrease of 0.55%. The firm decreased its portfolio allocation in TH by 12.68% over the last quarter.
Advisor Group Holdings holds 434K shares representing 0.45% ownership of the company. No change in the last quarter.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
